<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Cobîltean, L.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Dumbrava, V.A.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Proca, N.V.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='ro'>Sistemul de hemostază la pacienţii cu ciroză hepatică de diferită etiologie</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2011</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1857-1719</relatedIdentifier>
<dates>
<date dateType='Issued'>2011-06-01</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'>Hemostasis in patients with liver disease with diferent aetiology
The liver has an important role in the coagulation process, so it is not surprising that all
coagulation factors are produced in the liver. We have studied 116 patients with liver cirrhosis
with different aetiology of disease. There were 61 men and 55 women with mean age 50,3±0,3.
These patients were divided into 5 groups depending on aetiology of disease. We have estimated
and compared value of thrombocytes and plasmatic factors in these groups. There were
registered significant differences of haemostatic parameters in these groups.</description>
<description xml:lang='ro' descriptionType='Abstract'>Ficatul ocupă un rol important în sistemul de hemostază,deoarece majoritatea factorilor
de coagulare sunt sintetizaţi anume aici. Studiul dat a inclus 116 pacienţi cu ciroză hepatică de
diferită etiologie, 61 bărbaţi şi 55 femei cu vîrsta medie 50,3±0,7. Pacienţii au fost divizaţi în 5
grupuri în dependenţă de etiologia bolii. Au fost estimaţi şi comparaţi parametrii de hemostază,
care au inregistrat diferenţe semnificative vis-a-vis de grupul de control.</description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>